New Guidelines on Acute Coronary Syndromes: K...

Steven Nissen, MD, and Ashish Sarraju, MD, discuss early clinical data on Kylo-11, a novel therapy that produced substantial reductions in lipoprotein(a) for up to one year after a single injection. Lowering lipoprotein(a), a genetically determined cardiovascular risk factor link ...  Show more

Marc Gillinov, MD, and Per Wierup, MD, discuss the evolution of robotic valve surgery, including advanced mitral valve repair techniques, patient selection and expanding applications for aortic valve and coronary procedures. They examine how enhanced visualization, instrument dex ...  Show more

Obstructive hypertrophic cardiomyopathy therapy and septal reduction therapy via alcohol septal ablation and surgical myectomy is discussed by interventional cardiologist Dr. Amar Krishnaswamy and surgical perspective from cardiothoracic surgeon Dr. Per Wierup. Amit joins Dr. Lau ...  Show more

Congenital heart disease and pulmonic valve disease require a coordinated team approach that includes an initial evaluation, explanation of therapeutic options, innovative transcatheter and surgical therapies and consultative follow-up. Dr. Joanna Ghobrial discusses diagnosis and ...  Show more

KYW Newsradio’s Rasa Kaye discusses aortic valve disease with Deborah Heart and Lung Center's Interventional Cardiologist Dr. Richard Kovach. The conversation includes Deborah’s team approach to identifying, managing and treating the condition, and the latest advances in Trans ...

Drs Coats, Bozkurt, Metra, and Zieroth discuss important updates regarding the management of patients with heart failure.

Credit available for this activity expires: 11/22/2022
Earn Credit / Learning Objectives & Disclosures: <a href= "https://www.medscape.org/vie ...